Great West Life Assurance CO Adaptive Biotechnologies Corp Transaction History

Great West Life Assurance CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.88 - $4.8 $141,534 - $235,891	-49,144 Reduced 79.14%	12,950 $41,000
Q4 2023 Feb 13, 2024	SELL	$3.46 - $5.33 $7,003 - $10,787	-2,024 Reduced 3.16%	62,094 $302,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $42,146 - $70,161	8,313 Added 14.9%	64,118 $348,000
Q2 2023 Aug 10, 2023	BUY	$6.19 - $8.78 $138,556 - $196,531	22,384 Added 66.98%	55,805 $376,000
Q1 2023 May 12, 2023	SELL	$7.8 - $10.11 $49,818 - $64,572	-6,387 Reduced 16.04%	33,421 $295,000
Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $115,741 - $172,687	18,489 Added 86.73%	39,808 $305,000
Q3 2022 Nov 01, 2022	BUY	$6.5 - $12.67 $138,573 - $270,111	21,319 New	21,319 $152,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $18,449 - $27,011	-733 Reduced 13.65%	4,637 $130,000
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $29,696 - $53,988	-797 Reduced 12.92%	5,370 $215,000
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $47,485 - $69,070	1,055 Added 20.64%	6,167 $363,000
Q2 2020 Aug 17, 2020	BUY	$24.95 - $48.38 $127,544 - $247,318	5,112 New	5,112 $246,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $857M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.